Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Hui Ju Liu"'
Autor:
Szu-Chun Yang, Chien-Yu Lin, Ting-Hsing Chao, Chi-Hao Wu, Li-Jung Elizabeth Ku, Ta-Jung Chung, Hui-Ju Liu
Publikováno v:
BMJ Open, Vol 13, Iss 3 (2023)
Objectives Earlier research has evaluated the non-medical costs after lung cancer diagnosis. This study estimated the time costs and transportation costs associated with low-dose CT (LDCT) screening and diagnostic lung procedures in Taiwan.Design Cro
Externí odkaz:
https://doaj.org/article/2655a94b166840b995b9c25d53dd3966
Autor:
Yuan-Chin Hsieh, Jun-min Liao, Kuo-Hsiang Chuang, Kai-Wen Ho, Shih-Ting Hong, Hui-Ju Liu, Bo-Cheng Huang, I-Ju Chen, Yen-Ling Liu, Jaw-Yuan Wang, Hsiang-Lin Tsai, Yu-Cheng Su, Yen-Tseng Wang, Tian-Lu Cheng
Publikováno v:
Journal of Nanobiotechnology, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background Humanization of mouse monoclonal antibodies (mAbs) is crucial for reducing their immunogenicity in humans. However, humanized mAbs often lose their binding affinities. Therefore, an in silico humanization method that can prevent t
Externí odkaz:
https://doaj.org/article/682be9e061ff404fb8b92628dae0d0c1
Autor:
Wen-Wei Lin, Yun-Chi Lu, Bo-Cheng Huang, Chih-Hung Chuang, Yi-An Cheng, I.-Ju Chen, Hui-Ju Liu, Kai-Wen Ho, Tzu-Yi Liao, En-Shuo Liu, Ting-Yi Wu, Long-Sen Chang, Shih-Ting Hong, Tian-Lu Cheng
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Canakinumab is a fully human monoclonal antibody that specifically neutralizes human interleukin (IL)-1β and has been approved by the US Food and Drug Administration for treating different types of autoinflammatory disorders such as cryopyr
Externí odkaz:
https://doaj.org/article/cbc2120056d34be588820d88d63a8a3e
Autor:
Wen-Wei Lin, Yi-An Cheng, Chia-Ching Li, Kai-Wen Ho, Huei-Jen Chen, I.-J.u Chen, Bo-Cheng Huang, Hui-Ju Liu, Yun-Chi Lu, Chiu-Min Cheng, Ming-Yii Huang, Hung-Wen Lai, Tian-Lu Cheng
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Ovarian cancer is highly metastatic, with a high frequency of relapse, and is the most fatal gynecologic malignancy in women worldwide. It is important to elevate the drug susceptibility and cytotoxicity of ovarian cancer cells, thereby elim
Externí odkaz:
https://doaj.org/article/63d97e87db234af79d3c1e4526c6bbd3
Autor:
Kai-Wen Ho, I.-J.u Chen, Yi-An Cheng, Tzu-Yi Liao, En-Shuo Liu, Huei-Jen Chen, Yun-Chi Lu, Yu-Cheng Su, Steve R. Roffler, Bo-Cheng Huang, Hui-Ju Liu, Ming-Yii Huang, Chiao-Yun Chen, Tian-Lu Cheng
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-12 (2021)
Abstract Background Tumor-targeted nanoparticles hold great promise as new tools for therapy of liquid cancers. Furthermore, the therapeutic efficacy of nanoparticles can be improved by enhancing the cancer cellular internalization. Methods In this s
Externí odkaz:
https://doaj.org/article/90203a981820425d90aa6193a4e80d5c
Autor:
Kai-Wen Cheng, Chih-Hua Tseng, I.-Ju Chen, Bo-Cheng Huang, Hui-Ju Liu, Kai-Wen Ho, Wen-Wei Lin, Chih-Hung Chuang, Ming-Yii Huang, Yu-Lin Leu, Steve R. Roffler, Jaw-Yuan Wang, Yeh-Long Chen, Tian-Lu Cheng
Publikováno v:
Pharmacological Research, Vol 177, Iss , Pp 106115- (2022)
The bidirectional interaction between carcinogens and gut microbiota that contributes to colorectal cancer is complicated. Reactivation of carcinogen metabolites by microbial β-glucuronidase (βG) in the gut potentially plays an important role in co
Externí odkaz:
https://doaj.org/article/55f73cca8fc546a79e2f4bf887feeae5
Autor:
Chia-Ching Li, Chiu-Min Cheng, Yun-Chi Lu, Hung-Wen Lai, Kai-Wen Ho, I-Ju Chen, Yi-An Cheng, Ming-Yii Huang, Huei-Jen Chen, Hui-Ju Liu, Bo-Cheng Huang, Wen-Wei Lin, Tian-Lu Cheng
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports
Scientific Reports
Ovarian cancer is highly metastatic, with a high frequency of relapse, and is the most fatal gynecologic malignancy in women worldwide. It is important to elevate the drug susceptibility and cytotoxicity of ovarian cancer cells, thereby eliminating r
Autor:
Tian-Lu Cheng, I-Ju Chen, Yun Chi Lu, Yu-Cheng Su, Tzu Yi Liao, Yi An Cheng, Ming-Yii Huang, Kai Wen Ho, Steve R. Roffler, Huei Jen Chen, En Shuo Liu, Chiao Yun Chen, Hui Ju Liu, Bo Cheng Huang
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-12 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background Tumor-targeted nanoparticles hold great promise as new tools for therapy of liquid cancers. Furthermore, the therapeutic efficacy of nanoparticles can be improved by enhancing the cancer cellular internalization. Methods In this study, we
Autor:
Chi-Hao Wu, Li-Jung Elizabeth Ku, Chien-Yu Lin, Ta-Jung Chung, Hui-Ju Liu, Ting-Hsing Chao, Szu-Chun Yang
Publikováno v:
BMJ Open. 13:e070647
ObjectivesEarlier research has evaluated the non-medical costs after lung cancer diagnosis. This study estimated the time costs and transportation costs associated with low-dose CT (LDCT) screening and diagnostic lung procedures in Taiwan.DesignCross
Autor:
Kai-Wen Cheng, Chih-Hua Tseng, I.-Ju Chen, Bo-Cheng Huang, Hui-Ju Liu, Kai-Wen Ho, Wen-Wei Lin, Chih-Hung Chuang, Ming-Yii Huang, Yu-Lin Leu, Steve R. Roffler, Jaw-Yuan Wang, Yeh-Long Chen, Tian-Lu Cheng
Publikováno v:
Pharmacological research. 177
The bidirectional interaction between carcinogens and gut microbiota that contributes to colorectal cancer is complicated. Reactivation of carcinogen metabolites by microbial β-glucuronidase (βG) in the gut potentially plays an important role in co